Trial intelligence / Profile preview

Vancomycin and Gentamycin for Infective Endocarditis in Children

NCT03688659Unknown

Sponsor
Assiut University
Start
Jan 2019
Primary completion
Jan 2021
Modality
Nanoparticles, Implantable Devices, Cyclic Peptides
01

Overview

Open-label, single-arm trial of vancomycin and gentamicin in infective endocarditis (IE), sponsored by Assiut University. Primary endpoint: vancomycin and gentamycin in infective endocarditis at 2 weeks. Status: unknown.

02

Drugs

vancomycingentamicin
03

Conditions

infective endocarditis (IE)

Beyond the preview

Go deeper on NCT03688659.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03688659.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call